This announcement is a separate document:
华东医药：国盛证券有限责任公司关于华东医药股份有限公司2022年限制性股票激励计划首次授予限制性股票第二个解除限售期解除限售条件成就、调整限制性股票回购价格及回购注销部分限制性股票事项之独立财务顾问报告
Huadong Pharmaceutical: Independent Financial Advisory Report of Guosheng Securities Co., Ltd. on Huadong Pharmaceutical Co., Ltd.\'s 2022 Restricted Stock Incentive Plan grants restricted shares for the first time, the achievements of lifting sales restrictions during the second period of lifting restrictions, adjusting the repurchase price of restricted stocks, and the repurchase and cancellation of some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated